ThirdLaw Molecular: Funding, Investors & Team (Sep 2026)
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease treatment.
ThirdLaw Molecular has raised $5.5M across 1 funding round on record, the most recent a Seed of $5.5M announced in Oct 2025.
That round is below the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ThirdLaw Molecular Company Profile and Key Stats
Latest funding round on record: Oct 2025.
ThirdLaw Molecular Funding Rounds
ThirdLaw Molecular Founders and Leadership Team
Contact details for the ThirdLaw Molecular team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →ThirdLaw Molecular Funding Compared to Other Biotechnology Startups
ThirdLaw Molecular's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ThirdLaw Molecular in Biotechnology and Blue Bell
Companies Similar to ThirdLaw Molecular
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
ThirdLaw Molecular Funding FAQs
What does ThirdLaw Molecular do?
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease treatment.
How much funding has ThirdLaw Molecular raised?
ThirdLaw Molecular has raised $5.5M across 1 round on record. The most recent is a Seed of $5.5M announced in Oct 2025.
When did ThirdLaw Molecular last raise funding?
ThirdLaw Molecular's most recent funding round on record is a Seed of $5.5M, announced in Oct 2025.
Who is the CEO of ThirdLaw Molecular?
Christian Schafmeister is listed as CEO at ThirdLaw Molecular.
Where is ThirdLaw Molecular headquartered?
ThirdLaw Molecular is based in Blue Bell, United States.
How many employees does ThirdLaw Molecular have?
ThirdLaw Molecular is in the 1-10 employee band.
How does ThirdLaw Molecular's funding compare to other Biotechnology startups?
ThirdLaw Molecular's latest round of $5.5M is below the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's ThirdLaw Molecular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ThirdLaw Molecular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.